Vous ne pouvez pas changer la sélection. Uniquement autorisé quand vous avez aussi accès au gestionnaire de livre.

Rédacteur : Johan Nguyen

Sommaire

1. Systematic Reviews and Meta-Analysis
- 1.1. Generic Acupuncture
- 1.2. Special outcome
  - 1.2.1. Multiple Myeloma Peripheral Neuropathy
    - 1.2.1.1. Lyu 2024
2. Clinical Practice Guidelines
- 2.1. British Society for Haematology (BSH, UK) 2011 ⊕

Myeloma

Myélome : évaluation de l'acupuncture

1. Systematic Reviews and Meta-Analysis

1.1. Generic Acupuncture

1.2. Special outcome

1.2.1. Multiple Myeloma Peripheral Neuropathy

1.2.1.1. Lyu 2024

Lyu C, Xiao H, Yin X, Li Z, Han C, Xu R. Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review. J Pain Res. 2024 Apr 24;17:1571-1581. https://doi.org/10.2147/JPR.S448634

Backgound	Peripheral neuropathy (PN) is a prevalent complication of multiple myeloma (MM), due to the disease itself or its treatment. Despite extensive research, the optimal treatment for multiple myeloma peripheral neuropathy (MMPN) remains unclear. Clinical practice has shown the potential efficacy of acupuncture in managing MMPN. This study aimed to conduct a comprehensive analysis of the literature to assess the effectiveness and safety of acupuncture as a treatment for MMPN.
Methods	The PubMed, Web of Science, MEDLINE, Cochrane Library, and Embase databases were comprehensively searched from inception to November 1, 2023 to identify relevant studies pertaining to the use of acupuncture to treat MMPN.
Results	A total of five studies, encompassing 97 patients diagnosed with drug-related PN, were included. No studies addressed disease-related PN. ST36 , LI4, SP6, and EX-LE-10 were the most frequently selected acupoints. Acupuncture treatment was consistently associated with reductions in Visual Analogue Scale (VAS), Neuropathic Pain Scale (NPS), Brief Pain Inventory–Short Form (BPI-SF), and Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity (FACT/GOG-Ntx) scores. Results from nerve conduction velocity (NCV) assessments were inconsistent. No severe adverse effects were reported.
Conclusion	Acupuncture for disease-related PN in multiple myeloma has not yet been investigated. Acupuncture appears safe for drug-related PN and may help relieve pain, but substantial heterogeneity in treatment regimens and limited study quality preclude firm conclusions. Further high-quality studies are required.

2. Clinical Practice Guidelines

⊕ positive recommendation (regardless of the level of evidence reported)
Ø negative recommendation, (or lack of evidence)

2.1. British Society for Haematology (BSH, UK) 2011 ⊕

Snowden JA, Ahmedzai SH, Ashcroft J, D'Sa S, Littlewood T, Low E, Lucraft H, Maclean R, Feyler S, Pratt G, Bird JM; Haemato-oncology Task Force of British Committee for Standards in Haematology and UK Myeloma Forum. Guidelines for supportive care in multiple myeloma 2011. British Journal of Haematology. 2011;154(1):76-103. [168770] .

Complementary therapy [acupuncture] can offer benefit to myeloma patients when integrated with conventional medical treatments (Grade B recommendation; level Iib evidence)